Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 18c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.20), $0.18 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Brookfield Wealth Solutions Ltd. (BNT) Reports Q2 EPS of $0.07
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance